These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 17009028)

  • 1. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.
    Triesscheijn M; Ruevekamp M; Out R; Van Berkel TJ; Schellens J; Baas P; Stewart FA
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):113-22. PubMed ID: 17009028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
    Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
    Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.
    Buchholz J; Kaser-Hotz B; Khan T; Rohrer Bley C; Melzer K; Schwendener RA; Roos M; Walt H
    Clin Cancer Res; 2005 Oct; 11(20):7538-44. PubMed ID: 16243829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
    Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
    Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy.
    Glanzmann T; Hadjur C; Zellweger M; Grosiean P; Forrer M; Ballini JP; Monnier P; van den Bergh H; Lim CK; Wagnières G
    Photochem Photobiol; 1998 May; 67(5):596-602. PubMed ID: 9613244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue levels, histologic changes and plasma pharmacokinetics of meta-Tetra (hydroxyphenyl) chlorin (mTHPC) in the cat.
    Campbell GA; Bartels KE; Arnold C; Healey T; Cowell RL; Lucroy MD; Ronn AM
    Lasers Med Sci; 2002; 17(2):79-85. PubMed ID: 12111590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing meso-tetra-hydroxyphenyl-chlorin-mediated photodynamic therapy for basal cell carcinoma.
    Triesscheijn M; Ruevekamp M; Antonini N; Neering H; Stewart FA; Baas P
    Photochem Photobiol; 2006; 82(6):1686-90. PubMed ID: 16984216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts.
    Ris HB; Krueger T; Giger A; Lim CK; Stewart JC; Althaus U; Altermatt HJ
    Br J Cancer; 1999 Mar; 79(7-8):1061-6. PubMed ID: 10098737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC.
    Lassalle HP; Dumas D; Gräfe S; D'Hallewin MA; Guillemin F; Bezdetnaya L
    J Control Release; 2009 Mar; 134(2):118-24. PubMed ID: 19100297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
    Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G
    J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
    Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
    Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage selective photodynamic therapy by meta-tetra(hydroxyphenyl)chlorin loaded polymeric micelles: A possible treatment for cardiovascular diseases.
    Wennink JWH; Liu Y; Mäkinen PI; Setaro F; de la Escosura A; Bourajjaj M; Lappalainen JP; Holappa LP; van den Dikkenberg JB; Al Fartousi M; Trohopoulos PN; Ylä-Herttuala S; Torres T; Hennink WE; van Nostrum CF
    Eur J Pharm Sci; 2017 Sep; 107():112-125. PubMed ID: 28679107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of a tri-glucoconjugated 5,10,15-(meta)-trihydroxyphenyl-20-phenyl porphyrin photosensitizer for PDT. A single dose study in the rat.
    Desroches MC; Bautista-Sanchez A; Lamotte C; Labeque B; Auchère D; Farinotti R; Maillard P; Grierson DS; Prognon P; Kasselouri A
    J Photochem Photobiol B; 2006 Oct; 85(1):56-64. PubMed ID: 16765603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor selectivity at short times following systemic administration of a liposomal temoporfin formulation in a murine tumor model.
    Svensson J; Johansson A; Gräfe S; Gitter B; Trebst T; Bendsoe N; Andersson-Engels S; Svanberg K
    Photochem Photobiol; 2007; 83(5):1211-9. PubMed ID: 17880517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative sensitivity of microvascular endothelial cells, fibroblasts and tumor cells after in vitro photodynamic therapy with meso-tetra-hydroxyphenyl-chlorin.
    Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
    Photochem Photobiol; 2004; 80(2):236-41. PubMed ID: 15362947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy as novel nephron sparing treatment option for small renal masses.
    Kroeze SG; Grimbergen MC; Rehmann H; Bosch JL; Jans JJ
    J Urol; 2012 Jan; 187(1):289-95. PubMed ID: 22099991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis.
    Garrier J; Bressenot A; Gräfe S; Marchal S; Mitra S; Foster TH; Guillemin F; Bezdetnaya L
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):563-71. PubMed ID: 20656417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients.
    D'Cruz AK; Robinson MH; Biel MA
    Head Neck; 2004 Mar; 26(3):232-40. PubMed ID: 14999798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the TAT-RasGAP(317-326) peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light.
    Pittet O; Petermann D; Michod D; Krueger T; Cheng C; Ris HB; Widmann C
    J Photochem Photobiol B; 2007 Jul; 88(1):29-35. PubMed ID: 17560792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.